RNAInvestor Events•prnewswire•
Avidity Biosciences to Participate in Upcoming Investor Conferences
Sentiment:Negative (20)
Summary
SAN DIEGO, Aug. 27, 2025 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced that Avidity management will participate in a fireside...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 27, 2025 by prnewswire